Xylocaine Jelly 2% Zydus Healthcare Ltd.

£16.00

Xylocaine Jelly 2% Zydus Healthcare represents a topical anesthetic compound containing lidocaine hydrochloride for laboratory research applications examining local anesthetic mechanisms.

 

  • 30 days easy returns
  • Order yours before 2.30pm for same day dispatch
Xylocaine Jelly 2% Zydus Healthcare Ltd.
Xylocaine Jelly 2% Zydus Healthcare Ltd.
£16.00

[wpforms id=”1190″ title=”true” description=”Request a call back”]

Compound Profile: Xylocaine Jelly 2% Zydus Healthcare Ltd.

Xylocaine Jelly 2% Zydus Healthcare represents a pharmaceutical-grade topical anesthetic formulation containing lidocaine hydrochloride as the active component. This viscous gel preparation enables researchers at Stroid UK Shop to examine local anesthetic mechanisms in controlled laboratory environments. The compound provides opportunities to investigate sodium channel blocking properties and local tissue penetration characteristics in experimental models.

The 2% concentration formulation offers standardised research conditions for studying lidocaine’s pharmacokinetic profile and tissue distribution patterns. Researchers can evaluate the compound’s viscosity properties and examine how gel-based delivery affects active ingredient release rates. The Zydus Healthcare manufacturing ensures pharmaceutical-grade consistency for reproducible experimental outcomes across multiple research protocols within laboratory settings.

Research Applications

Scientists utilise Xylocaine Jelly preparations to investigate topical anesthetic mechanisms and local tissue response patterns. Research applications include examining sodium channel blockade kinetics, studying local vascular effects, and evaluating tissue penetration characteristics in experimental models. The gel formulation enables researchers to analyse sustained-release properties compared to alternative delivery methods available through our anesthetic drugs collection.

Laboratory studies frequently examine lidocaine’s interaction with neuronal membrane structures and investigate dose-response relationships in controlled experimental conditions. Researchers can compare this topical preparation’s efficacy profile against systemic anesthetic compounds found in our research chemical collections and peptide categories for comprehensive pharmacological analysis.

Specification Data

Xylocaine Jelly 2% Research Specifications
Parameter Value
Active Ingredient Lidocaine Hydrochloride 2%
Manufacturer Zydus Healthcare Ltd.
Formulation Topical Gel
CAS Number Verify with supplier
Molecular Formula Verify with supplier
Storage Requirements Room temperature, sealed container

Research Use Disclaimer

Xylocaine Jelly 2% Zydus Healthcare is supplied exclusively for in-vitro laboratory research purposes. This product is not intended for human consumption, clinical use, or therapeutic applications. Researchers must follow appropriate laboratory safety protocols and institutional guidelines when handling this anesthetic preparation. All studies should be conducted within controlled laboratory environments by qualified research personnel.

Related